{"nctId":"NCT00963508","briefTitle":"Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice","startDateStruct":{"date":"2009-08"},"conditions":["Pediculosis"],"count":403,"armGroups":[{"label":"Malathion Gel","type":"EXPERIMENTAL","interventionNames":["Drug: Malathion gel 0.5%"]},{"label":"Nix Crème Rinse","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Permethrin 1% rinse (Nix Crème)"]}],"interventions":[{"name":"Malathion gel 0.5%","otherNames":[]},{"name":"Permethrin 1% rinse (Nix Crème)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Confirmed active head lice infestation\n\nExclusion Criteria:\n\n* Allergy to pediculicides or hair care products\n* Scalp conditions other than head lice\n* Previous head lice treatment within the past 4 weeks\n* Current antibiotic treatment","healthyVolunteers":false,"sex":"ALL","minimumAge":"2 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Proportion of Index Subjects Free of Any Lice 14 Days After Their Last Treatment in the Modified ITT (LOCF)","description":"The primary efficacy variable was the proportion of index subjects who were considered a Treatment Success 14 days after their last treatment (Day 14 visit if only treated on Day 1, Day 21 visit if treated on Day 1 and Day 7)\n\nTreatment Success in the Efficacy ITT (LOCF)\n\nindex subjects: 150 from 403 randomized (the youngest subject in the household that met the index case criteria (having nits and at least 3 live lice))","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"86.67","spread":null},{"groupId":"OG001","value":"45.33","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Subjects Who Were Considered a Treatment Success 14 Days After Their First Treatment in the Modified ITT (LOCF).","description":"The secondary efficacy variable was the proportion of subjects who were considered a Treatment Success 14 days after their first treatment.\n\nTreatment Success in the Efficacy ITT (LOCF)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"89.90","spread":null},{"groupId":"OG001","value":"55.43","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":206},"commonTop":["APPLICATION SITE PRURITUS","APPLICATION SITE ERYTHEMA","APPLICATION SITE EROSION","APPLICATION SITE IRRITATION","CONJUNCTIVAL IRRITATION"]}}}